You have 9 free searches left this month | for more free features.

Leukemia,%20Lymphocytic,%20Chronic,%20B-Cell

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukemia, Lymphocytic, Chronic, B-Cell, Small Lymphocytic Lymphoma Trial (Ibrutinib, Venetoclax)

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Small Lymphocytic Lymphoma
  • (no location specified)
Jul 19, 2023

Chronic Lymphocytic Leukemia Trial (Loncastuximab Tesirine)

Not yet recruiting
  • Chronic Lymphocytic Leukemia
  • Loncastuximab Tesirine
  • (no location specified)
Jul 24, 2023

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Chronic Lymphocytic, Small-Cell Lymphoma Trial (Nemtabrutinib, Venetoclax,

Not yet recruiting
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +5 more
  • (no location specified)
Jul 21, 2023

Chronic Lymphocytic Leukemia Patients

Not yet recruiting
  • Chronic Lymphocytic Leukemia
    • San Francisco, California
      Power Life Sciences
    Jun 2, 2023

    Relapsed or Refractory CD19+ B-cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small

    Recruiting
    • Relapsed or Refractory CD19+ B-cell Lymphoma
    • +2 more
    • TBI-2001
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jul 26, 2023

    Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Durham (Myeloma Coach or CLL Coach Mobile App, Springboard Beyond Cancer

    Completed
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Myeloma Coach or CLL Coach Mobile App
    • Springboard Beyond Cancer informational website
    • Durham, North Carolina
      Duke University
    Jun 23, 2023

    Chronic Lymphocytic Leukemia Trial (Acalabrutinib, Obinutuzumab)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • (no location specified)
    Jul 10, 2023

    Biomarker for Infection Risk in CLL and MM

    Not yet recruiting
    • Multiple Myeloma
    • Chronic Lymphocytic Leukemia
    • Screening
    • Boston, Massachusetts
      Massachusetts General Hospital Cancer Center
    May 3, 2023

    Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

    Recruiting
    • Non-hodgkin Lymphoma
    • +2 more
    • CC312
    • Tianjin, Tianjin, China
      InstituteHBDH
    Sep 12, 2023

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial (Nemtabrutinib, Ibrutinib, Acalabrutinib)

    Not yet recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • (no location specified)
    Nov 22, 2023

    Orelabrutinib in Treatment of Chronic Lymphocytic Leukemia/Small

    Recruiting
    • CLL/SLL
    • Jinan, Shandong, China
      Department of Hematology, Shandong Provincial Hospital Affiliate
    Jun 16, 2023

    CLL Trial (Sonrotoclax, Zanubrutinib, Venetoclax)

    Not yet recruiting
    • CLL
    • (no location specified)
    Oct 3, 2023

    Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
    • +6 more
    • (no location specified)
    Apr 12, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell Trial in New York (Zanubrutinib Pill, Venetoclax Pill, Obinutuzumab Injection)

    Not yet recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Zanubrutinib Pill
    • +2 more
    • New York, New York
      Weill Cornell Medicine/NewYork-Presberteryian Hospital
    Dec 6, 2022

    Determination of Blood Tumor Cells

    Completed
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Abnormalities Cell Epithelial
      • Zurich, Switzerland
        University Hospital Zurich
      Jan 9, 2023

      Lymphoproliferative Disorders, Premalignant, Monoclonal B-Cell Lymphocytosis Trial (No intervention)

      Not yet recruiting
      • Lymphoproliferative Disorders
      • +3 more
      • No intervention
      • (no location specified)
      Jan 30, 2023

      B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
        • Manhasset, New York
          Feinstein Institute for Medical Research
        Jul 6, 2022

        Relapsed/Refractory Chronic Lymphocytic Leukemia Trial in Tianjin (GNC-035)

        Not yet recruiting
        • Relapsed/Refractory Chronic Lymphocytic Leukemia
        • Tianjin, Tianjin, China
          Institute of Hematology and Blood Diseases Hospital, Chinese Aca
        Jul 13, 2023

        "Don't Eat me" Signal in Hematological Malignancies: CD24 as New

        Recruiting
        • Mantle-cell Lymphoma
        • B Cell Chronic Lymphocytic Leukemia
          • Monza, MB, Italy
            Andrea Aroldi
          May 24, 2023

          Chronic Lymphocytic Leukemia Trial in Houston (Questionnaires, Fit Bit)

          Recruiting
          • Chronic Lymphocytic Leukemia
          • Questionnaires
          • Fit Bit
          • Houston, Texas
            M D Anderson Cancer Center
          May 18, 2023

          Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin Trial in Worldwide (JNJ-67856633, Ibrutinib)

          Active, not recruiting
          • Leukemia, Lymphocytic, Chronic, B-Cell
          • Lymphoma, Non-Hodgkin
          • Copenhagen, Denmark
          • +9 more
          Jan 27, 2023

          Understanding Chronic Lymphocytic Leukemia

          Recruiting
          • Chronic Lymphocytic Leukemia
            • Boston, Massachusetts
              Dana Farber Cancer Institute
            Aug 1, 2022

            Chronic Lymphocytic Leukemia, B-Cell Chronic Lymphocytic Leukemia, Lymphoma, B-Cell Trial run by the National Cancer Institute

            Not yet recruiting
            • Chronic Lymphocytic Leukemia
            • +2 more
            • Anti-CD19 and anti-CD20 bicistronic CAR T- cells
            • +2 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Apr 10, 2023

            B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

            Not yet recruiting
            • B-cell Non Hodgkin Lymphoma
            • Chronic Lymphocytic Leukemia
            • Cyclophosphamide injection
            • +2 more
            • Charleston, South Carolina
              Hollings Cancer Center at Medical University of South Carolina
            Jan 18, 2023

            Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance

            Not yet recruiting
            • Previously Untreated Chronic Lymphocytic Leukaemia (Including Small Lymphocytic Lymphoma)
              • (no location specified)
              Dec 16, 2022